Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Classifica tra le azioni #13231
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Prezzo delle azioni
$4.99
Capitalizzazione di mercato
$508.03M
Variazione (1 giorno)
-2.48%
Variazione (1 anno)
2.10%
Paese
TW
Scambia Ever Supreme Bio Technology Co., Ltd (6712)

Categoria

EPS per Ever Supreme Bio Technology Co., Ltd (6712)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Ever Supreme Bio Technology Co., Ltd, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Ever Supreme Bio Technology Co., Ltd da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH